Genetic Polymorphisms in the Chemokine and Chemokine Receptors: Impact on Clinical Course and Therapy of the Human Immunodeficiency Virus Type 1 Infection (HIV-1)

Publisher： Bentham Science Publishers

E-ISSN： 1875-533x|14|12|1325-1334

ISSN： 0929-8673

Source： Current Medicinal Chemistry, Vol.14, Iss.12, 2007-05, pp. : 1325-1334

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

CCR5 Chemokine Receptors: Gatekeepers of HIV-1 Infection

By  

Current Drug Targets - Infectious Disorders, Vol. 2, Iss. 3, 2002-09 ,pp. : 265-278

Bentham Science Publishers

Access to resources Recommend Favorite

Immunoreactive Cycloimmunogen Design Based on Conformational Epitopes Derived from Human Immunodeficiency Virus Type 1 Coreceptors:Cyclic Dodecapeptides Mimic Undecapeptidyl Arches of Extracellular Loop-2 in Chemokine Receptor and Inhibit Human Immunodeficiency Virus Type 1 Infection

By  

Endocrine, Metabolic & Immune Disorders-Drug Targets (Formerly Current Drug Targets - Immune, Endocrine & Metabolic Disorders), Vol. 7, Iss. 2, 2007-06 ,pp. : 141-152

Bentham Science Publishers

Access to resources Recommend Favorite

Chemokine receptors: interaction with HIV-1 and viral-encoded chemokines

By Sozzani S.   Allavena P.   Vecchi A.   Van Damme J.   Mantovani A.  

Pharmaceutica Acta Helvetiae, Vol. 74, Iss. 2, 2000-03 ,pp. : 305-312

Elsevier

Access to resources Recommend Favorite

The Vif protein of Human Immunodeficiency Virus Type 1 (HIV-1): Enigmas and Solutions [General Articles]

By  

Current Medicinal Chemistry, Vol. 11, Iss. 2, 2004-01 ,pp. : 221-231

Bentham Science Publishers

Access to resources Recommend Favorite

Human immunodeficiency virus 1 (HIV-1) reverse transcriptase (RT)

By Argyris E.   Paterson Y.  

Expert Opinion on Therapeutic Targets, Vol. 2, Iss. 2, 1998-12 ,pp. : 239-243

Informa Healthcare

Access to resources Recommend Favorite